Cargando…
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study
INTRODUCTION: For patients with perihilar cholangiocarcinoma (CCA), surgery is the only treatment modality that can result in cure. Unfortunately, in the majority of these patients, the tumours are found to be unresectable at presentation due to either local invasive tumour growth or the presence of...
Autores principales: | Koedijk, Merel S, Heijmen, Ben J M, Groot Koerkamp, Bas, Eskens, Ferry A L M, Sprengers, Dave, Poley, Jan-Werner, van Gent, Dik C, van der Laan, Luc J W, van der Holt, Bronno, Willemssen, François E J A, Méndez Romero, Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196820/ https://www.ncbi.nlm.nih.gov/pubmed/30327398 http://dx.doi.org/10.1136/bmjopen-2017-020731 |
Ejemplares similares
-
Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study
por: Baak, Rogier, et al.
Publicado: (2021) -
Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021) -
Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma
por: Gaspersz, Marcia P., et al.
Publicado: (2019) -
Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020) -
Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
por: de Jong, David M., et al.
Publicado: (2023)